Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yi Ping Hsiang"'
Autor:
Yi-Ping Hsiang, Yi-Ting Wang, Keng-Shiang Huang, Ting-Yu Huang, Mi-Hsueh Tai, Yu-Mei Lin, Chih-Hui Yang, Jei-Fu Shaw
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250565 (2021)
The purity of chlorophylls plays one of the key role for the production of chlorophyllides. We have designed a facile method for chlorophyll purification by twice solvent extraction. Twice extraction causes the loss of chlorophylls, but the purity of
Externí odkaz:
https://doaj.org/article/01c8da5e8464464daee181a9ec639f32
Autor:
Chun-Ting Lee, Keng-Shiang Huang, Jei-Fu Shaw, Jung-Ren Chen, Wen-Shuo Kuo, Gangxu Shen, Alexandru Mihai Grumezescu, Alina Maria Holban, Yi-Ting Wang, Jun-Sheng Wang, Yi-Ping Hsiang, Yu-Mei Lin, Hsiao-Han Hsu, Chih-Hui Yang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Cordyceps militaris (C. militaris) is a fungus with a long history of widespread use in folk medicine, and its biological and medicinal functions are well studied. A crucial pharmacological effect of C. militaris is immunomodulation. In this review,
Externí odkaz:
https://doaj.org/article/38403e41a96c4985b5639451169a92a0
Autor:
Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang, Yi-Ping Hsiang, Chau-Chyun Sheu, Yung-Che Chen, Meng-Chih Lin, Kuo-An Chu, Cheng-Hung Lee, Yu-Feng Wei
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Long-acting muscarinic antagonist (LAMA) monotherapy is recommended for chronic obstructive pulmonary disease (COPD) patients with high risk of exacerbations. It is unclear whether long-acting β2-agonist (LABA)/LAMA fixed-dose combinatio
Externí odkaz:
https://doaj.org/article/5f49346c471a43f5b6b32c47a743e583
Autor:
Chih-Hui Yang, Wen-Shuo Kuo, Jun-Sheng Wang, Yi-Ping Hsiang, Yu-Mei Lin, Yi-Ting Wang, Fan-Hsuan Tsai, Chun-Ting Lee, Jiun-Hua Chou, Huei-Ya Chang, Lung-Shuo Wang, Shu-Chi Wang, Keng-Shiang Huang
Publikováno v:
Evidence-Based Complementary and Alternative Medicine.
Background. Chronic kidney disease (CKD) is a critical public health issue with a huge financial burden for both patients and society worldwide. Unfortunately, there are currently no efficacious therapies to prevent or delay the progression of end-st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd47d0cdeee119af2ecc7ccc05f814a
Autor:
Chih-Hui, Yang, Wen-Shuo, Kuo, Jun-Sheng, Wang, Yi-Ping, Hsiang, Yu-Mei, Lin, Yi-Ting, Wang, Fan-Hsuan, Tsai, Chun-Ting, Lee, Jiun-Hua, Chou, Huei-Ya, Chang, Lung-Shuo, Wang, Shu-Chi, Wang, Keng-Shiang, Huang
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM. 2022
Chronic kidney disease (CKD) is a critical public health issue with a huge financial burden for both patients and society worldwide. Unfortunately, there are currently no efficacious therapies to prevent or delay the progression of end-stage renal di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c20278ce93d8f47a3b31926d5999970
https://pubmed.ncbi.nlm.nih.gov/35368765
https://pubmed.ncbi.nlm.nih.gov/35368765
Autor:
Pei Hsuan Chien, Yung Jun Hung, Lei Chin Chen, Hsiao Lin Pan, Yun Ju Chen, Yi Ping Hsiang, Ching Ting Wei
Publikováno v:
Anticancer Research. 39:695-701
Background/aim Sorafenib is now standard treatment for advanced hepatocellular carcinoma (HCC). However, therapeutic efficacy is not as good as was predicted. Many efforts are being made to improve HCC sensitivity to sorafenib. Our previous study dem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e34f7065f8c6df5e691e5f3dab14a49
https://doi.org/10.21873/anticanres.13165
https://doi.org/10.21873/anticanres.13165
Autor:
Chih-Hui Yang, Mi-Hsueh Tai, Keng-Shiang Huang, Yi-Ting Wang, Jei-Fu Shaw, Ting-Yu Huang, Yu-Mei Lin, Yi-Ping Hsiang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 4, p e0250565 (2021)
PLoS ONE, Vol 16, Iss 4, p e0250565 (2021)
The purity of chlorophylls plays one of the key role for the production of chlorophyllides. We have designed a facile method for chlorophyll purification by twice solvent extraction. Twice extraction causes the loss of chlorophylls, but the purity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dde73b7330a79b51914b4b5dbb76b8a
https://doi.org/10.1371/journal.pone.0250565
https://doi.org/10.1371/journal.pone.0250565
Autor:
Yun Ju Chen, Kung Chuan Cheng, Yi Ping Hsiang, Chih I. Chen, Yueh Ming Lin, Hsiao Lin Pan, Pei Hsuan Chien, Shu Chuan Pi, Chien Chang Lu
Publikováno v:
Journal of cellular physiology. 234(7)
Cyclooxygenase-2 (COX-2) is frequently overexpressed and enhances colorectal cancer (CRC) tumorigenesis, including cancer stem cell (CSC) regulation. Accordingly, nonsteroidal anti-inflammatory drugs (NSAIDs), inhibiting COX-1/2 activity, are viewed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de66dbc799c1f368fdf68bab38082d3
https://pubmed.ncbi.nlm.nih.gov/30480806
https://pubmed.ncbi.nlm.nih.gov/30480806
Autor:
Yueh Ming Lin, Yun Ju Chen, Chih I. Chen, Pei Hsuan Chien, Kung Chuan Cheng, Yung Chia Hsu, Chien Chang Lu, Hsiao Lin Pan, Yi Ping Hsiang
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 6, p 1763 (2018)
International Journal of Molecular Sciences
Volume 19
Issue 6
International Journal of Molecular Sciences
Volume 19
Issue 6
Chemotherapeutic 5-fluorouracil (5-FU) combined with oxaliplatin is often used as the standard treatment for colorectal cancer (CRC). The disturbing side effects and drug resistance commonly observed in chemotherapy motivate us to develop alternative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa23fd7f0c3eb339487e99cce64ef0c1
http://www.mdpi.com/1422-0067/19/6/1763
http://www.mdpi.com/1422-0067/19/6/1763
Autor:
Wang Chun Chen, Chau-Chyun Sheu, Ching Yi Chen, Kuo An Chu, Chi Hsien Huang, Meng-Chih Lin, Cheng Hung Lee, Yu-Feng Wei, Yi Ping Hsiang, Yung-Che Chen
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Long-acting muscarinic antagonist (LAMA) monotherapy is recommended for chronic obstructive pulmonary disease (COPD) patients with high risk of exacerbations. It is unclear whether long-acting β2-agonist (LABA)/LAMA fixed-dose combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be72a03375099736fa5ed1bf2063966d
https://doi.org/10.1177/1753466620937194
https://doi.org/10.1177/1753466620937194